Image
New Insights Into Rheumatoid Arthritis Pathophysiology Module 6

Leonard H. Calabrese, DO; John R. P. Tesser, MD

Jointly provided by the Elsevier Office of Continuing Medical Education and Integritas Communications

 

This activity has been supported by an independent educational grant from Gilead Sciences, Inc., and Sanofi Genzyme and Regeneron Pharmaceuticals.

Faculty

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Vice Chair, Department of Rheumatic and Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic Foundation
Cleveland, Ohio

John R. P. Tesser, MD
Rheumatologist, Arizona Arthritis and Rheumatology Associates, PC
Adjunct Assistant Professor
Midwestern University Division of Clinical Education
Phoenix, Arizona
Adjunct Clinical Associate Professor
Midwestern University College of Health Sciences
Glendale, Arizona

Course Description

This CME-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing international treat-to-target guidelines as well as the mechanistic profiles and clinical evidence for therapies designed to inhibit signaling via interleukin-6 (IL-6) or members of the Janus kinase (JAK) family of enzymes. Some of the modules also include 3D-animated elements to illustrate the relationships between the heterogeneous pathophysiologic mechanisms underlying RA and certain targeted biologic or synthetic disease-modifying treatment options.

Target Audience

This activity has been designed to meet the educational needs of rheumatologists and other clinicians involved in the ongoing management of patients with RA.

Educational Objectives

Upon completion of this activity, participants will be better able to do the following:

  • Describe the proinflammatory cellular and cytokine networks underlying localized and systemic RA pathophysiology

Disclosure of Conflicts of Interest

It is the policy of the Elsevier Office of Continuing Medical Education that all faculty, instructors, and planners disclose any real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Leonard H. Calabrese, DO: Consultant/Advisor: AbbVie Inc.; Crescendo Bioscience, Inc.; Genentech, Inc.; Gilead Sciences, Inc.; Horizon Pharma plc; Janssen Pharmaceuticals, Inc.; Medimmune, LLC; Pfizer Inc.; UCB, Inc. Speakers' Bureau: AbbVie Inc.; Crescendo Bioscience, Inc.; Genentech, Inc.; Horizon Pharma plc; Janssen Pharmaceuticals, Inc.; Medimmune, LLC; UCB, Inc.

John R.P. Tesser, MD: Consultant/Advisor: Eli Lilly and Company; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi-Genzyme. Speakers’ Bureau: AbbVie Inc.; Eli Lilly and Company; Genentech, Inc.; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi-Genzyme. Research Grant: AbbVie Inc.; Eli Lilly and Company; Genentech, Inc.; Gilead Sciences, Inc.; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi-Genzyme. Employment (spouse): Regeneron Pharmaceuticals, Inc.

Non-faculty

Rose O’Connor, PhD; Jim Kappler, PhD; Sandy Breslow; Alison Kemp; and Bernard M. Abrams, MD, hereby state that neither they nor their spouses/life partners have any financial relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. 

CME Credit (Physicians) 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Elsevier Office of Continuing Medical Education and Integritas Communications. The Elsevier Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Elsevier Office of Continuing Medical Education designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Inquiries/Special Needs

For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, Integritas Communications, Gilead Sciences, Inc., and Sanofi Genzyme and Regeneron Pharmaceuticals do not recommend the use of any agent outside of the labeled indications.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Course Instructions

In order to claim credit, participants must complete the following:

  1. Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions.
  3. Read or review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Physicians who achieves a grade of 100% or better on the Post-Activity Test and who completes the Evaluation will receive a CME Certificate.
  6. All other participant who achieves a grade of 100% or better on the Post-Activity Test Questions and who completes the Evaluation will receive a Certificate of Participation.

Click "Begin Activity" to acknowledge that you have reviewed the preamble information for this activity.

Begin Activity

credit amount 0.25

credit type CME/CE

release 11/13/2018

expiration 11/12/2019

type SnapShot